Heart Screening (CCHD)

Congenital Heart Disease is the most common and deadly of all birth defects. Approximately 25 percent of these cases are considered to be “Critical” Congenital Heart Disease (CCHD), particularly hard to detect in the newborn period. CCHD screening has also been proven to be important in identifying secondary conditions (e.g. neonatal sepsis, persistent pulmonary hypertension, parenchymal or anatomic pulmonary disease, transient tachypnea of the newborn, hypothermia, and hemoglobinopathies).  These secondary conditions can be detrimental to the newborn if not diagnosed and treated.1, 2  OZ Telepathy™ CCHD screening solution provides the utmost accuracy in CCHD screening with clinical decision support at the time of screening.

OZ CCHD Solution:

  • Developed with renowned nursing experts in CCHD screening from Children’s National Medical Center, Heart Institute
  • Improve the outcome for newborns when a timely and accurate diagnosis is critical
  • Provide messaging between a hospital’s electronic health record and OZ software solutions using OZ Newborn Admission Notification Information (NANI™)
  • Capture multiple screening values from the pulse oximeter directly into the OZ Telepathy™ CCHD (optional)
  • Provide direct clinical decision support to ensure accurate results based on your selected protocol
  • Transfer the screening results into the OZ eSP™—an integrated child health database—and on to your hospital EHR, other providers or directly to state public health programs
  • Provide nurse sensitive quality indicators to monitor program success
  • Allow for the monitoring outcomes of the clinical decision support algorithm chosen by your state

Hear what our customers say

1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227333/ 2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567069/